Anecova, the swiss medtech company, is proud to announce the birth of a healthy baby boy thanks to the application of its innovative in vivo approach to assisted reproductive treatment.
For the first time in this field, a baby was born after in vivo fertilization and then developing fully in the womb of his mother.
This birth constitutes a first in the world for the company dedicated to help families facing fertility issues.
|